Schulz J, Hartz A, Bauer B
Pharmacol Rev. 2023; 75(5):815-853.
PMID: 36973040
PMC: 10441638.
DOI: 10.1124/pharmrev.120.000025.
Gampa G, Kenchappa R, Mohammad A, Parrish K, Kim M, Crish J
Sci Rep. 2020; 10(1):6524.
PMID: 32300151
PMC: 7162859.
DOI: 10.1038/s41598-020-63494-7.
Stompor M, Uram L, Podgorski R
Molecules. 2017; 22(7).
PMID: 28665345
PMC: 6152326.
DOI: 10.3390/molecules22071092.
Xi G, Hayes E, Lewis R, Ichi S, Mania-Farnell B, Shim K
Oncogene. 2015; 35(2):241-50.
PMID: 25823028
DOI: 10.1038/onc.2015.78.
Goldwirt L, Beccaria K, Carpentier A, Idbaih A, Schmitt C, Levasseur C
J Neurooncol. 2015; 122(2):273-81.
PMID: 25794638
DOI: 10.1007/s11060-015-1717-1.
Therapeutic strategies to improve drug delivery across the blood-brain barrier.
Azad T, Pan J, Connolly I, Remington A, Wilson C, Grant G
Neurosurg Focus. 2015; 38(3):E9.
PMID: 25727231
PMC: 4493051.
DOI: 10.3171/2014.12.FOCUS14758.
Multidrug resistance-associated protein MRP1 expression in human gliomas: chemosensitization to vincristine and etoposide by indomethacin in human glioma cell lines overexpressing MRP1.
Benyahia B, Huguet S, Decleves X, Mokhtari K, Criniere E, Bernaudin J
J Neurooncol. 2004; 66(1-2):65-70.
PMID: 15015771
DOI: 10.1023/b:neon.0000013484.73208.a4.
P-glycoprotein and multidrug resistance-associated protein mediate specific patterns of multidrug resistance in malignant glioma cell lines, but not in primary glioma cells.
Bahr O, Rieger J, Duffner F, Meyermann R, Weller M, Wick W
Brain Pathol. 2003; 13(4):482-94.
PMID: 14655754
PMC: 8095903.
DOI: 10.1111/j.1750-3639.2003.tb00479.x.
Drug resistance-associated factors in primary and secondary glioblastomas and their precursor tumors.
Tews D, Nissen A, Kulgen C, Gaumann A
J Neurooncol. 2001; 50(3):227-37.
PMID: 11263502
DOI: 10.1023/a:1006491405010.
Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma.
Haga S, Hinoshita E, Ikezaki K, Fukui M, Scheffer G, Uchiumi T
Jpn J Cancer Res. 2001; 92(2):211-9.
PMID: 11223551
PMC: 5926688.
DOI: 10.1111/j.1349-7006.2001.tb01084.x.
Expression of multidrug resistance-associated protein (MRP) in human gliomas.
Mohri M, Nitta H, Yamashita J
J Neurooncol. 2001; 49(2):105-15.
PMID: 11206006
DOI: 10.1023/a:1026528926482.
Expression of multidrug resistance protein gene in patients with glioma after chemotherapy.
Abe T, Mori T, Wakabayashi Y, Nakagawa M, Cole S, Koike K
J Neurooncol. 1999; 40(1):11-8.
PMID: 9874181
DOI: 10.1023/a:1005954406809.
The molecular biology of ependymomas.
Hamilton R, Pollack I
Brain Pathol. 1997; 7(2):807-22.
PMID: 9161731
PMC: 8098521.
DOI: 10.1111/j.1750-3639.1997.tb01066.x.
MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors.
Toth K, Vaughan M, Peress N, Slocum H, Rustum Y
Am J Pathol. 1996; 149(3):853-8.
PMID: 8780389
PMC: 1865160.
Ultrastructural localization of P-glycoprotein on capillary endothelial cells in human gliomas.
Tanaka Y, Abe Y, Tsugu A, Takamiya Y, Akatsuka A, Tsuruo T
Virchows Arch. 1994; 425(2):133-8.
PMID: 7952498
DOI: 10.1007/BF00230349.
Drug resistance in brain tumors.
Feun L, Savaraj N, Landy H
J Neurooncol. 1994; 20(2):165-76.
PMID: 7807193
DOI: 10.1007/BF01052726.
Fluorescent dye rhodamine 6G as a molecular probe to study drug resistance of C6 rat glioma cells.
Matsumoto Y, Sasaoka N, Tsuchida T, Fujiwara T, Nagao S, Ohmoto T
J Neurooncol. 1992; 13(3):217-22.
PMID: 1517798
DOI: 10.1007/BF00172473.
